Related Experiment Video
Updated: Jun 16, 2026
08:47
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
[Encephalopathy by hyperammonemia in teenagers]
B Zalba1, T Serrano, C Velilla
1Unidad de Cuidados Intensivos, Hospital Clínico Universitario, Avenida San Juan Bosco no. 15, Zaragoza, Spain. bzalba2002@yahoo.es
Anales Del Sistema Sanitario De Navarra
|January 23, 2010
Summary
This case highlights the critical need for prompt diagnosis and treatment of hyperammonemia, a condition causing central nervous system alterations. Early intervention is key to improving outcomes for patients with hyperammonemia.
Area of Science:
- Neurology
- Metabolic Disorders
- Pediatrics
Background:
- Hyperammonemia significantly impacts the central nervous system.
- Non-hepatic causes of hyperammonemia necessitate thorough investigation for accurate diagnosis.
Observation:
- A 16-year-old presented with acute encephalopathy and hyperammonemia.
- Diagnostic imaging included brain CT, ultrasound, and abdominal Doppler.
- Empirical treatment targeted urea cycle disorders, with management of cerebral edema and ammonia reduction.
Findings:
- Despite interventions, the patient's condition did not improve.
- The patient unfortunately passed away four days after admission.
Implications:
- Complex hyperammonemia management demands a multidisciplinary team approach.
- Early etiological identification and treatment are crucial for reducing high morbidity and mortality rates associated with hyperammonemia.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:23Urea Cycle
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...